The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)
National Institutes of Health
Classification and identifiers
- Solicitation number
- RFA-AG-27-005
- Assistance listing (CFDA)
- 93.866
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to develop, operate, and sustain a cloud-based data storage and computing platform that democratizes access to large-scale Alzheimer’s disease (AD) and AD-related dementias (ADRD) genetic and genomic data. The platform must be secure, scalable, and interoperable. The platform will support the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS), the primary NIA-supported repository for the archiving and distribution of human genetic data related to AD/ADRD. The purpose of the platform will be to: Enable efficient ingestion, curation, harmonization, and analysis of multi-ancestry, large population-scale datasets; Provide robust analysis, visualization, and artif...
Related opportunities
- Research Project Cooperative Agreements in Aging and/or Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) ResearchNational Institutes of Health
- Resource-Related Research Projects Cooperative Agreements in Aging and/or Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) ResearchNational Institutes of Health
- Specialized Center Cooperative Agreements in Aging and/or Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) ResearchNational Institutes of Health
- Alzheimer's Disease Programs Initiative (ADPI) - Dementia Capability in Indian CountryAdministration for Community LivingCloses in 16 daysUp to $300K
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)National Institutes of Health
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029